Skip to main content

Farxiga fɔ Tayp 2 Dayabitis - Lɛ wi lan ɛksaktɔli bɔt dis mɛrɛsin!

Farxiga fɔ Tayp 2 Dayabitis - Lɛ wi lan ɛksaktɔli bɔt dis mɛrɛsin!

Dayabitis na wɛlbɔdi prɔblɛm we bɔku pipul dɛn na wi sosayti de gɛt tide. Na mɔtalman, Tayp 2 Dayabitis kin apin pan ɛni ej. Wit dis sik, de risk fɔ gɛt bɔku ɔda wɛl bɔdi prɔblɛm dɛn bak kin bɔku. So, bɔrku kayn mɛrɛsin de wae dɔktɔ dɛn kin se fɔ kɔntrol dis shuga. Wan pan dɛn drɔgs dɛn de na Farxiga. Tide, insay dis atikul, wi go tɔk bɔt di impɔtant tin dɛn we yu fɔ no if yu dɔktɔ gi yu dis mɛrɛsin.

Aw Farxiga de wok insay di bɔdi?

Dis drɔg, we de ɔnda di brand nem Farxiga, gɛt di aktif ingridiɛnt dapagliflozin . dis dεm de pan wan klas כf dεm we dεn kכl SGLT2 inhibito dεm. Naw lɛ wi si wetin dis na simpul wɔd dɛn.

Tink bɔt wi kidni dɛn lɛk tu supa filta dɛn. Dɛn filta ya kin klin wi blɔd ɛn pul tin dɛn we wi nɔ want tru di urine. dis we ya, di shuga (glucose) we de insay di bכdi de filta bak insay di urine. Bɔt wi bɔdi rili kɔni. we yu yuz wan protin we dεn kכl SGLT2 na di kidni dεm, i de riabsכp di shuga we de tray fכ go insay di urine. Pɔsin we gɛt dayabitis dɔn ɔlrɛdi gɛt bɔku shuga na in bɔdi. So fɔ tek shuga bak nɔto gud tin.

Farxiga de wok bay we i de blok di akshכn fכ di SGLT2 protin . Dis min se di shuga nɔ de go insay di bɔdi igen, bɔt insted i de kɔmɔt na di urine. Fɔ tɔk am simpul wan, di men wok we dis mɛrɛsin de du na fɔ kɔntrol di shuga we de na yu blɔd bay we i de pul di shuga we pasmak na yu bɔdi tru di urine .

Wetin na di tin dɛn we kin kɔmɔt frɔm dis mɛrɛsin?

Dɛn dɔn stɔdi bɔt Farxiga bɔku bɔku wan ɔlsay na di wɔl. Dɛn stɔdi ya dɔn sho se i kin rili ɛp fɔ mek di blɔd shuga go dɔŋ, we dɛn yuz am in wan ɛn we dɛn yuz am wit ɔda mɛrɛsin dɛn fɔ gɛt dayabitis.

Dɛn dɔn yuz Farxiga wit dɛn mɛrɛsin ya we dɛn kin yuz fɔ mɛn dayabitis:

  • Metfɔmin we dɛn kɔl
  • Sɔlfonylureas (ɛgz., Gliklazayd, Glimepiride) .
  • GLP-1 rεsεptכr agonist dεm
  • Insulin we dɛn kin yuz
  • DPP-4 inhibito dεm
  • Tiazolidindiɔn dɛn we dɛn kin yuz

di men tin we dεn de luk pan dεn stכdi dεm ya na wan valyu we dεn kכl HbA1c (hεmoglobin A1c). Fɔ tɔk am simpul wan, HbA1c na yu avɛrej blɔd shuga lɛvɛl fɔ di pas 2-3 mɔnt . I tan lɛk ‘ripɔt kad’ fɔ yu dayabitis kɔntrol. Insay bɔku stɔdi dɛn, pipul dɛn we bin yuz Farxiga bin gɛt bɔku lɔwa HbA1c lɛvɛl.

Aw lɔng i kin tek fɔ si di rizɔlt?

Yu blɔd shuga lɛvɛl go bigin fɔ drɔp klos wan afta yu bigin fɔ tek Farxiga. If yu na pɔsin we de chɛk yu blɔd shuga na os, yu go si big difrɛns insay di fɔs 4 wik.Yu kin si am. Bɔt i kin tek sɔm tɛm fɔ mek di HbA1c valyu go dɔŋ. Bikɔs na avrej 2-3 mɔnt, i kin tek lɛk 8 to 12 wik fɔ si chenj na da valyu de.

Ɛni ɔda bɛnifit dɛn de apat frɔm we i de ridyus di shuga?

Yɛs! Pan ɔl we di men wok we Farxiga de du na fɔ kɔntrol di blɔd shuga, risach dɔn sho se i gɛt bɔku ɔda bɛnifit dɛn. Dis kin rili impɔtant fɔ pɔsin we gɛt dayabitis.

Ɔda bɛnifit we dɛn go gɛt Simpul ɛksplen
We yu de lɔs yu wet Dis nɔto pil we de mek pɔsin nɔ gɛt bɔku bɔku bɔdi. Bɔt bikɔs shuga kin kɔmɔt na di urine, di kalori dɛn we de insay da shuga de kin kɔmɔt bak na di bɔdi. fכ dat, dεn fכnshכn se pipul dεm we de tek dis pil de lכs lεk 1.5 - 3.5 kg (3.5 - 7 paund).
Di blɔd prɛshɔn we de go dɔŋ Dis nɔto mɛrɛsin fɔ blɔd prɛshɔn. Bɔt we shuga kɔmɔt na di urine, smɔl wata de kɔmɔt bak na di bɔdi. Dis kin mek di blɔd prɛshɔn go dɔŋ smɔl.
Ridyus ɔspitul layf bikɔs ɔf at sik Dɛn dɔn sho se dis mɛrɛsin kin ridyus di risk fɔ go na ɔspitul bikɔs yu at nɔ de wok fayn if yu gɛt at sik ɔ tin dɛn we kin mek yu gɛt am (kɔlestrol, ay blɔd prɛshɔn, smok).
Kidni protɛkshɔn Dayabitis kin pwɛl yu kidni dɛn as tɛm de go. If yu gɛt krɛse sik, Farxiga kin ɛp bak fɔ mek i nɔ wɔs.

Wetin na di sayd ɛfɛkt dɛm fɔ dis mɛrɛsin?

Lɛk ɛni mɛrɛsin, Farxiga kin mek sɔm smɔl smɔl sayd ɛfɛkt dɛn. I impɔtant fɔ no bɔt dɛn tin ya.

1. Infεkshכn dεm we de na di jεnital yist

Dis na di mɔs kɔmɔn sayd ɛfɛkt fɔ Farxiga. di hכy shuga we de insay di urine de mek fayn envayroment fכ fכn lεk yist fכ gro. Dis kin apin mɔ pan uman dɛn.

  • di sayn dεm: I de it na di jεnital εria, di wata we de smεl bad bad wan.
  • Aw fɔ manej?
  • Wear kɔtɔn ɔndawea.
  • Ɔltɛm kip di say we yu kin put yu bɔdi dray.
  • Tɔk to yu dɔktɔ ɛn gɛt di rayt tritmɛnt.

2. Hypoglycemia - Tu lכw bכdi shuga lεvεl

Dis kכndyushכn nכ kin apin we dεn tek Farxiga in wan. Bɔt if yu tek Farxiga wit insulin ɔ wan sulfonylurea (e.g., Gliclazide) , yu blɔd shuga lɛvɛl kin tu smɔl.

  • Di sayn dɛm: yu de swet, yu de shek shek, yu de angri pasmak, yu de tɔn diziz.
  • Manejmɛnt: We yu bigin fɔ gi Farxiga, yu dɔktɔ kin nid fɔ ridyus di doz fɔ yu ɔda dayabitis mɛrɛsin dɛn. Tɔk to yu dɔktɔ bɔt dis.

3. Dayabitik Kɛtoasidɔsis (DKA) .

Dis na siriɔs tin bɔt we nɔ kin apin so ɔltɛm. We di bɔdi nɔ ebul fɔ yuz shuga fɔ gɛt ɛnaji, i de bɔn fat fɔ gɛt ɛnaji. We dɛn de du dis, dɛn kin mek kemikal dɛn we dɛn kɔl ketɔn. Dɛn tin ya kin gɛda na di blɔd, we kin mek di blɔd tɔn to asid, we dɛn kɔl DKA.

  • Di sayn dɛm: I kin tɔsti pasmak, yu kin pis bɔku tɛm, yu bɛlɛ kin kramp, yu kin nɔs, yu kin vɔmit, yu nɔ kin ebul fɔ blo, ɛn yu kin gɛt frut smel na yu briz.
  • Wetin fɔ du: Dis na mɛdikal imejensi we kin mek pɔsin in layf de pan denja. If yu gɛt wan ɔ mɔ pan dɛn sik ya, yu fɔ go wantɛm wantɛm na di Imejɛnsi Dipatmɛnt (ETU) na di ɔspitul we de nia yu.

Aw a go gɛt Farxiga?

Farxiga nɔto drɔg we yu kin jɔs bay ova di kɔwnta na famasi. I nid fɔ gɛt prɛskrishɔn frɔm dɔktɔ.

Yu praymari kia ɔr wan dɔktɔ we de mɛn yu ɛndokrin go chɛk yu wɛlbɔdi ɛn no if dis mɛrɛsin fayn fɔ yu. Nɔ ɛva yuz dis mɛrɛsin ɔ chenj di doz we dɛn gi yu if yu nɔ go to dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Farxiga (dapagliflozin) na mɛrɛsin fɔ tayp 2 dayabitis. I de ɛp fɔ kɔntrol di blɔd shuga bay we i de pul di shuga we pasmak na di bɔdi tru di urine.
  • Apat frɔm we i de kɔntrol di shuga, i de ɛp bak fɔ ridyus di bɔdi wet ɛn blɔd prɛshɔn smɔl, i nɔ de mek pɔsin gɛt at sik, ɛn i de protɛkt di kidni dɛn.
  • Yist infεkshכn na di jεnital εria na wan kכmכn sayd ifekt. I impɔtant fɔ mek wi kɔntinyu fɔ klin.
  • Risk de fɔ mek yu gɛt haypoglycemia we yu tek am wit ɔda mɛrɛsin dɛn fɔ gɛt dayabitis lɛk insulin. Tɛl yu dɔktɔ bɔt dis.
  • Yu fɔ no di sayn dɛm fɔ wan siriɔs sik wae dɛn kɔl DKA. If yu gɛt dawt, go na ɔspitul in Imejɛnsi Dipatmɛnt (ETU) wantɛm wantɛm.
  • Dis mɛrɛsin fɔ jɔs yuz am if dɔktɔ tɛl yu fɔ yuz am .

Dayabitis, Farxiga, dapagliflozin, tayp 2 dayabitis, SGLT2 inhibito, shuga kɔntrol, dayabitis mɛrɛsin
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 1 + 7 =
Farxiga fɔ Tayp 2 Dayabitis - Lɛ wi lan ɛksaktɔli bɔt dis mɛrɛsin!

Farxiga fɔ Tayp 2 Dayabitis - Lɛ wi lan ɛksaktɔli bɔt dis mɛrɛsin!

Dayabitis na wɛlbɔdi prɔblɛm we bɔku pipul dɛn na wi sosayti de gɛt tide. Na mɔtalman, Tayp 2 Dayabitis kin apin pan ɛni ej. Wit dis sik, de risk fɔ gɛt bɔku ɔda wɛl bɔdi prɔblɛm dɛn bak kin bɔku. So, bɔrku kayn mɛrɛsin de wae dɔktɔ dɛn kin se fɔ kɔntrol dis shuga. Wan pan dɛn drɔgs dɛn de na Farxiga. Tide, insay dis atikul, wi go tɔk bɔt di impɔtant tin dɛn we yu fɔ no if yu dɔktɔ gi yu dis mɛrɛsin.

Aw Farxiga de wok insay di bɔdi?

Dis drɔg, we de ɔnda di brand nem Farxiga, gɛt di aktif ingridiɛnt dapagliflozin . dis dεm de pan wan klas כf dεm we dεn kכl SGLT2 inhibito dεm. Naw lɛ wi si wetin dis na simpul wɔd dɛn.

Tink bɔt wi kidni dɛn lɛk tu supa filta dɛn. Dɛn filta ya kin klin wi blɔd ɛn pul tin dɛn we wi nɔ want tru di urine. dis we ya, di shuga (glucose) we de insay di bכdi de filta bak insay di urine. Bɔt wi bɔdi rili kɔni. we yu yuz wan protin we dεn kכl SGLT2 na di kidni dεm, i de riabsכp di shuga we de tray fכ go insay di urine. Pɔsin we gɛt dayabitis dɔn ɔlrɛdi gɛt bɔku shuga na in bɔdi. So fɔ tek shuga bak nɔto gud tin.

Farxiga de wok bay we i de blok di akshכn fכ di SGLT2 protin . Dis min se di shuga nɔ de go insay di bɔdi igen, bɔt insted i de kɔmɔt na di urine. Fɔ tɔk am simpul wan, di men wok we dis mɛrɛsin de du na fɔ kɔntrol di shuga we de na yu blɔd bay we i de pul di shuga we pasmak na yu bɔdi tru di urine .

Wetin na di tin dɛn we kin kɔmɔt frɔm dis mɛrɛsin?

Dɛn dɔn stɔdi bɔt Farxiga bɔku bɔku wan ɔlsay na di wɔl. Dɛn stɔdi ya dɔn sho se i kin rili ɛp fɔ mek di blɔd shuga go dɔŋ, we dɛn yuz am in wan ɛn we dɛn yuz am wit ɔda mɛrɛsin dɛn fɔ gɛt dayabitis.

Dɛn dɔn yuz Farxiga wit dɛn mɛrɛsin ya we dɛn kin yuz fɔ mɛn dayabitis:

  • Metfɔmin we dɛn kɔl
  • Sɔlfonylureas (ɛgz., Gliklazayd, Glimepiride) .
  • GLP-1 rεsεptכr agonist dεm
  • Insulin we dɛn kin yuz
  • DPP-4 inhibito dεm
  • Tiazolidindiɔn dɛn we dɛn kin yuz

di men tin we dεn de luk pan dεn stכdi dεm ya na wan valyu we dεn kכl HbA1c (hεmoglobin A1c). Fɔ tɔk am simpul wan, HbA1c na yu avɛrej blɔd shuga lɛvɛl fɔ di pas 2-3 mɔnt . I tan lɛk ‘ripɔt kad’ fɔ yu dayabitis kɔntrol. Insay bɔku stɔdi dɛn, pipul dɛn we bin yuz Farxiga bin gɛt bɔku lɔwa HbA1c lɛvɛl.

Aw lɔng i kin tek fɔ si di rizɔlt?

Yu blɔd shuga lɛvɛl go bigin fɔ drɔp klos wan afta yu bigin fɔ tek Farxiga. If yu na pɔsin we de chɛk yu blɔd shuga na os, yu go si big difrɛns insay di fɔs 4 wik.Yu kin si am. Bɔt i kin tek sɔm tɛm fɔ mek di HbA1c valyu go dɔŋ. Bikɔs na avrej 2-3 mɔnt, i kin tek lɛk 8 to 12 wik fɔ si chenj na da valyu de.

Ɛni ɔda bɛnifit dɛn de apat frɔm we i de ridyus di shuga?

Yɛs! Pan ɔl we di men wok we Farxiga de du na fɔ kɔntrol di blɔd shuga, risach dɔn sho se i gɛt bɔku ɔda bɛnifit dɛn. Dis kin rili impɔtant fɔ pɔsin we gɛt dayabitis.

Ɔda bɛnifit we dɛn go gɛt Simpul ɛksplen
We yu de lɔs yu wet Dis nɔto pil we de mek pɔsin nɔ gɛt bɔku bɔku bɔdi. Bɔt bikɔs shuga kin kɔmɔt na di urine, di kalori dɛn we de insay da shuga de kin kɔmɔt bak na di bɔdi. fכ dat, dεn fכnshכn se pipul dεm we de tek dis pil de lכs lεk 1.5 - 3.5 kg (3.5 - 7 paund).
Di blɔd prɛshɔn we de go dɔŋ Dis nɔto mɛrɛsin fɔ blɔd prɛshɔn. Bɔt we shuga kɔmɔt na di urine, smɔl wata de kɔmɔt bak na di bɔdi. Dis kin mek di blɔd prɛshɔn go dɔŋ smɔl.
Ridyus ɔspitul layf bikɔs ɔf at sik Dɛn dɔn sho se dis mɛrɛsin kin ridyus di risk fɔ go na ɔspitul bikɔs yu at nɔ de wok fayn if yu gɛt at sik ɔ tin dɛn we kin mek yu gɛt am (kɔlestrol, ay blɔd prɛshɔn, smok).
Kidni protɛkshɔn Dayabitis kin pwɛl yu kidni dɛn as tɛm de go. If yu gɛt krɛse sik, Farxiga kin ɛp bak fɔ mek i nɔ wɔs.

Wetin na di sayd ɛfɛkt dɛm fɔ dis mɛrɛsin?

Lɛk ɛni mɛrɛsin, Farxiga kin mek sɔm smɔl smɔl sayd ɛfɛkt dɛn. I impɔtant fɔ no bɔt dɛn tin ya.

1. Infεkshכn dεm we de na di jεnital yist

Dis na di mɔs kɔmɔn sayd ɛfɛkt fɔ Farxiga. di hכy shuga we de insay di urine de mek fayn envayroment fכ fכn lεk yist fכ gro. Dis kin apin mɔ pan uman dɛn.

  • di sayn dεm: I de it na di jεnital εria, di wata we de smεl bad bad wan.
  • Aw fɔ manej?
  • Wear kɔtɔn ɔndawea.
  • Ɔltɛm kip di say we yu kin put yu bɔdi dray.
  • Tɔk to yu dɔktɔ ɛn gɛt di rayt tritmɛnt.

2. Hypoglycemia - Tu lכw bכdi shuga lεvεl

Dis kכndyushכn nכ kin apin we dεn tek Farxiga in wan. Bɔt if yu tek Farxiga wit insulin ɔ wan sulfonylurea (e.g., Gliclazide) , yu blɔd shuga lɛvɛl kin tu smɔl.

  • Di sayn dɛm: yu de swet, yu de shek shek, yu de angri pasmak, yu de tɔn diziz.
  • Manejmɛnt: We yu bigin fɔ gi Farxiga, yu dɔktɔ kin nid fɔ ridyus di doz fɔ yu ɔda dayabitis mɛrɛsin dɛn. Tɔk to yu dɔktɔ bɔt dis.

3. Dayabitik Kɛtoasidɔsis (DKA) .

Dis na siriɔs tin bɔt we nɔ kin apin so ɔltɛm. We di bɔdi nɔ ebul fɔ yuz shuga fɔ gɛt ɛnaji, i de bɔn fat fɔ gɛt ɛnaji. We dɛn de du dis, dɛn kin mek kemikal dɛn we dɛn kɔl ketɔn. Dɛn tin ya kin gɛda na di blɔd, we kin mek di blɔd tɔn to asid, we dɛn kɔl DKA.

  • Di sayn dɛm: I kin tɔsti pasmak, yu kin pis bɔku tɛm, yu bɛlɛ kin kramp, yu kin nɔs, yu kin vɔmit, yu nɔ kin ebul fɔ blo, ɛn yu kin gɛt frut smel na yu briz.
  • Wetin fɔ du: Dis na mɛdikal imejensi we kin mek pɔsin in layf de pan denja. If yu gɛt wan ɔ mɔ pan dɛn sik ya, yu fɔ go wantɛm wantɛm na di Imejɛnsi Dipatmɛnt (ETU) na di ɔspitul we de nia yu.

Aw a go gɛt Farxiga?

Farxiga nɔto drɔg we yu kin jɔs bay ova di kɔwnta na famasi. I nid fɔ gɛt prɛskrishɔn frɔm dɔktɔ.

Yu praymari kia ɔr wan dɔktɔ we de mɛn yu ɛndokrin go chɛk yu wɛlbɔdi ɛn no if dis mɛrɛsin fayn fɔ yu. Nɔ ɛva yuz dis mɛrɛsin ɔ chenj di doz we dɛn gi yu if yu nɔ go to dɔktɔ.

Mɛsej we dɛn kin kɛr go na os

  • Farxiga (dapagliflozin) na mɛrɛsin fɔ tayp 2 dayabitis. I de ɛp fɔ kɔntrol di blɔd shuga bay we i de pul di shuga we pasmak na di bɔdi tru di urine.
  • Apat frɔm we i de kɔntrol di shuga, i de ɛp bak fɔ ridyus di bɔdi wet ɛn blɔd prɛshɔn smɔl, i nɔ de mek pɔsin gɛt at sik, ɛn i de protɛkt di kidni dɛn.
  • Yist infεkshכn na di jεnital εria na wan kכmכn sayd ifekt. I impɔtant fɔ mek wi kɔntinyu fɔ klin.
  • Risk de fɔ mek yu gɛt haypoglycemia we yu tek am wit ɔda mɛrɛsin dɛn fɔ gɛt dayabitis lɛk insulin. Tɛl yu dɔktɔ bɔt dis.
  • Yu fɔ no di sayn dɛm fɔ wan siriɔs sik wae dɛn kɔl DKA. If yu gɛt dawt, go na ɔspitul in Imejɛnsi Dipatmɛnt (ETU) wantɛm wantɛm.
  • Dis mɛrɛsin fɔ jɔs yuz am if dɔktɔ tɛl yu fɔ yuz am .

Dayabitis, Farxiga, dapagliflozin, tayp 2 dayabitis, SGLT2 inhibito, shuga kɔntrol, dayabitis mɛrɛsin
⚠️ Important: The medical articles and information on Nirogi Lanka are for general awareness only, and are by no means a substitute for professional medical advice, diagnosis, or treatment. For any medical problem you have, consult a qualified physician immediately.

💬 Comments (0)

No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.

Ad yu kɔmɛnt

Duya kɔlkul: 1 + 7 =